Invicta Diagnostic Limited IPO Review
Neutral80-80 · SME
✦
Analyst Verdict
Invicta Diagnostic Limited IPO
Neutral
IPO at a Glance
Price Band
80-80
Issue Size
28cr
Min. Investment
₹1,28,000
Opens
2025-11-29
Closes
2025-12-01
Listing
2025-12-06
Category
SME
Key Strengths
✓Integrated diagnostic service provider with both radiology and pathology offerings.
✓Operates a scalable hub-and-spoke model enabling efficiency and wider reach.
✓Experienced promoters with strong medical and industry backgrounds.
✓Growing network of diagnostic centres in high-demand urban regions.
✓Strong focus on technology, quality systems, and modern diagnostic equipment.
Key Risks
⚠Business heavily depends on promoters’ expertise and continued involvement.
⚠High capital expenditure and equipment maintenance may impact profitability.
⚠Industry faces intense competition from established diagnostic chains.
⚠Regulatory changes in healthcare and diagnostics may affect operations.
⚠Revenue concentration in limited geographical regions increases business risk.
Frequently Asked Questions
Should I apply for Invicta Diagnostic Limited IPO?
Based on our analysis, our rating for Invicta Diagnostic Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Invicta Diagnostic Limited IPO?
Business heavily depends on promoters’ expertise and continued involvement. High capital expenditure and equipment maintenance may impact profitability. Industry faces intense competition from established diagnostic chains.
What are the strengths of Invicta Diagnostic Limited IPO?
Integrated diagnostic service provider with both radiology and pathology offerings. Operates a scalable hub-and-spoke model enabling efficiency and wider reach. Experienced promoters with strong medical and industry backgrounds.
What is the price band of Invicta Diagnostic Limited IPO?
The price band for Invicta Diagnostic Limited IPO is 80-80. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more